# Saline Enhanced Radiofrequency (SERF) Needle Ablation for Refractory VT

Study · id `cardio:ct-nct05337241` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05337241](<https://clinicaltrials.gov/study/NCT05337241>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05337241

Browse, organ or system: Heart  
Browse, condition area: Heart rhythm problems  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 130 participants.

## Technical summary

Registry record NCT05337241. Allocation not applicable; no masking; primary purpose treatment. Start 2025-08-09 (actual); primary completion 2027-06-30 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 130 participants (planned count; ClinicalTrials.gov record NCT05337241, source copy `cardio:ctgov-nct05337241-2025-08-14`, retrieved 2026-10-26)
- Started: 2025-08-09 (actual) (ClinicalTrials.gov record NCT05337241, source copy `cardio:ctgov-nct05337241-2025-08-14`, retrieved 2026-10-26)
- Primary completion: 2027-06-30 (anticipated) (ClinicalTrials.gov record NCT05337241, source copy `cardio:ctgov-nct05337241-2025-08-14`, retrieved 2026-10-26)
- Completion: 2027-06-30 (anticipated) (ClinicalTrials.gov record NCT05337241, source copy `cardio:ctgov-nct05337241-2025-08-14`, retrieved 2026-10-26)
- Countries: United States; Canada (ClinicalTrials.gov record NCT05337241, source copy `cardio:ctgov-nct05337241-2025-08-14`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05337241-2025-08-14`, retrieved 2026-10-26)

## The registry's words

- Brief title: Saline Enhanced Radiofrequency (SERF) Needle Ablation for Refractory VT
- Condition: Refractory Ventricular Tachycardia
- Intervention (Device): Saline Enhanced Radiofrequency (SERF) Ablation
- Lead sponsor: Thermedical, Inc.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Ventricular tachycardia (`cardio:ventricular-tachycardia`)

## Provenance

Content hash: 8620e26721b683a8455b8fc71635669e651212c7a02365e2f8408e50c6c0885c
Last substantive edit: 2026-10-31
Evidence last checked: Not recorded
